Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2011 Feb;14(2):146-50.
doi: 10.3779/j.issn.1009-3419.2011.02.08.

[Expression and clinical significance of ZO-1 in patients with non-small cell lung cancer]

[Article in Chinese]
Affiliations

[Expression and clinical significance of ZO-1 in patients with non-small cell lung cancer]

[Article in Chinese]
Yekai Wang et al. Zhongguo Fei Ai Za Zhi. 2011 Feb.

Abstract

Background and objective: It has been proven that the expression of ZO-1 (zonula occluden-1) was correlated with the growth and metastasis of cancer. The aim of this study is to investigate the relationship between ZO-1 gene expression and clinicopathologic parameters and the survival rates in the patients with non-small cell lung cancer (NSCLC).

Methods: The expression levels of ZO-1 gene in 101 patients with NSCLC and lung tissues of 61 patients with benign lung disease were detected by real-time PCR, Western blot and immunohistochemical techniques.

Results: There was a significant statistic difference of ZO-1 mRNA expression levels between carcinoma group and control group (P < 0.01). In carcinoma group, adjacent group and control group, ZO-1 protein expression levels were with significantly statistic difference between each other (P < 0.01 or P < 0.05). There was a significantly statistic difference between ZO-1 mRNA expression levels in survival during 2 years follow-up group and death during 2 years follow-up group (t=-5.61, P < 0.01).

Conclusions: ZO-1 is a valuable predictive marker for NSCLC patients.

背景与目的: 已有的研究表明紧密连接蛋白-1(zonula occluden-1, ZO-1)表达和肿瘤细胞的生长和转移存在密切联系。本研究旨在探讨非小细胞肺癌(non-small cell lung cancer, NSCLC)组织中ZO-1表达的临床意义。

方法: 应用实时荧光定量PCR、Western blot和免疫组化检测101例NSCLC癌组织及癌旁组织中ZO-1 mRNA和蛋白表达,以61例肺部良性病变患者作为对照。

结果: ZO-1 mRNA在癌组织和肺良性病变组织间差异具有统计学意义(P<0.01)。Western blot显示:ZO-1蛋白在癌组织、癌旁组织、肺良性病变组织的相对表达量之间均存在明显差异(P<0.01或P<0.05)。免疫组化显示:ZO-1平均光密度在癌组织、癌旁组织和肺良性病变组织中分别为69.55± 17.13、246.39±83.15、330.93±72.44,组间差异均具有统计学意义(P<0.01)。伴有淋巴结转移与不伴淋巴结转移肺癌组织ZO-1 mRNA表达水平比较有显著性差异(t=-5.07, P<0.01),肺癌患者术后2年内生存组和2年内死亡组间ZO-1 mRNA表达水平比较差异具有统计学意义(t=5.61, P<0.01)。

结论: ZO-1 mRNA和蛋白在NSCLC癌组织中表达降低,并与淋巴结转移的术后生存有密切关系。

PubMed Disclaimer

Figures

1
1
肺癌患者癌组织、癌旁组织和对照组中ZO-1蛋白表达。A:Wester blot检测ZO-1表达;B:柱状分析图表明ZO-1表达在癌组织、癌旁组织和对照组中的差异存在明显差异;泳道1-2:癌旁组织;泳道3-4:对照组;泳道5-6:癌组织;*:与对照组相比,P<0.05;**:与对照组相比,P<0.01;##:与癌旁组相比,P<0.01。 Expression of ZO-1 protein in carcinoma tissue group, adjacent tissue group and control group. A: Expression of ZO-1 protein determined by Western blot; B: The densitometric analysis reveal that the levels of ZO-1 protein among the carcinoma tissue group, the adjacent tissue group and the control group were with significantly statistic difference; Lane 1-2: adjacent tissue group; Lane 3-4: control group; Lane 5-6: carcinoma tissue group; *: compared with the control group, P < 0.05; **: compared with the control group, P < 0.01; ##: compared with the adjacent tissue group, P < 0.01.
2
2
NSCLC患者肺组织中ZO-1免疫组化。A:ZO-1在肺组织中的免疫组化(SP,×20);B:柱状分析图表明ZO-1表达在癌组织、癌旁组织和对照组中的差异存在显著统计学意义;**:与对照组相比,P<0.01;##:与癌旁组相比,P<0.01。 Immunohistochemical assessmen of ZO-1 in lung tissue of patients with NSCLC. A: Immunohistochemical assessmen of ZO-1 in lung tissue (SP, ×20). In adjacent tissue of gland cancer and control group, ZO-1 distributed through the alveolar walls completely. But in carcinoma tissue of gland cancer, ZO-1 distributed through the alveolar walls incompletely; there is a low expression of ZO-1 between the gland cancer cells; B: The densitometric analysis reveal that the averages of the optical densities of ZO-1 protein among the carcinoma tissue group, the adjacent tissue group and the control group were significant statistic different; **: compared with the control group, P < 0.01; ##: compared with the adjacent tissue group, P < 0.01.

Similar articles

Cited by

References

    1. Ding GR, Qiu LB, Wang XW, et al. EMP-induced alterations of tight junction protein expression and disruption of the blood-brain barrier. Toxicol Lett. 2010;196(3):154–160. doi: 10.1016/j.toxlet.2010.04.011. - DOI - PubMed
    1. Zhang JB, Du XG, Zhang H, et al. Breakdown of the gut barrier in patients with multiple organ dysfunction syndrome is attenuated by continuous blood purification: effects on tight junction structural proteins. Int J Artif Organs. 2010;33(1):5–14. doi: 10.1177/039139881003300102. - DOI - PubMed
    1. Fanning AS, Ma TY, Anderson JM. Isolation and functional characterization of the actin binding region in the tight junction protein ZO-1. FASEB J. 2002;16(13):1835–1837. doi: 10.1096/fj.02-0121fje. - DOI - PubMed
    1. Yu D, Marchiando AM, Weber CR, et al. MLCK-dependent exchange and actin binding region-dependent anchoring of ZO-1 regulate tight junction barrier function. Proc Natl Acad Sci USA. 2010;107(18):8237–8241. doi: 10.1073/pnas.0908869107. - DOI - PMC - PubMed
    1. Jinn Y, Inase N. Connexin 43, E-cadherin, beta-catenin and ZO-1 expression, and aberrant methylation of the connexin 43 gene in NSCLC. http://europepmc.org/abstract/med/20651379. Anticancer Res. 2010;30(6):2271–2278. - PubMed

Publication types

MeSH terms